Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Logo for

J. Biol. Chem. 279 (40): 41504-41511

© 2004 by The American Society for Biochemistry and Molecular Biology, Inc.

Antizyme Targets Cyclin D1 for Degradation



Ruchi M. Newman{ddagger}§¶, Arian Mobascher¶||**, Ursula Mangold{ddagger}, Chieko Koike{ddagger}{ddagger}{ddagger}, Sri Diah{ddagger}§§, Marion Schmidt||¶¶, Daniel Finley||, , and Bruce R. Zetter{ddagger}||||||

{ddagger}Program in Vascular Biology and Department of Surgery, Children's Hospital, and the ||Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115

Abstract: Overproduction of the ornithine decarboxylase (ODC) regulatory protein ODC-antizyme has been shown to correlate with cell growth inhibition in a variety of different cell types. Although the exact mechanism of this growth inhibition is not known, it has been attributed to the effect of antizyme on polyamine metabolism. Antizyme binds directly to ODC, targeting ODC for ubiquitin-independent degradation by the 26 S proteasome. We now show that antizyme induction also leads to degradation of the cell cycle regulatory protein cyclin D1. We demonstrate that antizyme is capable of specific, noncovalent association with cyclin D1 and that this interaction accelerates cyclin D1 degradation in vitro in the presence of only antizyme, cyclin D1, purified 26 S proteasomes, and ATP. In vivo, antizyme up-regulation induced either by the polyamine spermine or by antizyme overexpression causes reduction of intracellular cyclin D1 levels. The antizyme-mediated pathway for cyclin D1 degradation is independent of the previously characterized phosphorylation- and ubiquitination-dependent pathway, because antizyme up-regulation induces the degradation of a cyclin D1 mutant (T286A) that abrogates its ubiquitination. We propose that antizyme-mediated degradation of cyclin D1 by the proteasome may provide an explanation for the repression of cell growth following antizyme up-regulation.

Received for publication June 30, 2004. Revision received July 20, 2004.

* This work was supported by United States Public Health Service Grant CA37393 (to B. R. Z.) and by a grant from Aventis (to B. R. Z. and D. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


The on-line version of this article (available at contains an additional figure.

§ Present address: The Burnham Institute, 10901 N. Torrey Pines Rd., La Jolla, CA 92037.

These authors contributed equally to this work.

** Present address: Rheinische Kliniken Duesseldorf, Dept. of Psychiatry, Duesseldorf University, Bergische Landstr. 2, 40629 Duesseldorf, Germany. Supported by a fellowship from Dr. Mildred Scheel-Stiftung fuer Krebsforschung.

{ddagger}{ddagger} Present address: The 4th Department, Osaka Bioscience Institute, 6-2-4 Furue-dai, Suita, Osaka 562-0874, Japan.

§§ Present address: NIEHS, Maildrop F3-04, Rm. F312, 111 Alexander Dr., Research Triangle Park, NC 27709.

¶¶ Supported by a fellowship from the Deutsche Forschungsgemeinschaft.

|||| To whom correspondence should be addressed: Karp Bldg., Rm. 11.125, Children's Hospital, 300 Longwood Ave., Boston, MA 02115. Tel.: 617-919-2320; Fax: 617-730-0268; E-mail: Bruce.Zetter{at}

Amino Acids Regulate Expression of Antizyme-1 to Modulate Ornithine Decarboxylase Activity.
R. M. Ray, M. J. Viar, and L. R. Johnson (2012)
J. Biol. Chem. 287, 3674-3690
   Abstract »    Full Text »    PDF »
Non-canonical ubiquitin-based signals for proteasomal degradation.
Y. Kravtsova-Ivantsiv and A. Ciechanover (2012)
J. Cell Sci. 125, 539-548
   Abstract »    Full Text »    PDF »
Genetic Reevaluation of the Role of F-Box Proteins in Cyclin D1 Degradation.
T. Kanie, I. Onoyama, A. Matsumoto, M. Yamada, H. Nakatsumi, Y. Tateishi, S. Yamamura, R. Tsunematsu, M. Matsumoto, and K. I. Nakayama (2012)
Mol. Cell. Biol. 32, 590-605
   Abstract »    Full Text »    PDF »
Evidence of a Role for Antizyme and Antizyme Inhibitor as Regulators of Human Cancer.
R. R. Olsen and B. R. Zetter (2011)
Mol. Cancer Res. 9, 1285-1293
   Abstract »    Full Text »    PDF »
Antizyme Affects Cell Proliferation and Viability Solely through Regulating Cellular Polyamines.
Z. Bercovich, Z. Snapir, A. Keren-Paz, and C. Kahana (2011)
J. Biol. Chem. 286, 33778-33783
   Abstract »    Full Text »    PDF »
Parkin Mediates Proteasome-dependent Protein Degradation and Rupture of the Outer Mitochondrial Membrane.
S. R. Yoshii, C. Kishi, N. Ishihara, and N. Mizushima (2011)
J. Biol. Chem. 286, 19630-19640
   Abstract »    Full Text »    PDF »
SLUG-induced Elevation of D1 Cyclin in Breast Cancer Cells through the Inhibition of Its Ubiquitination.
M. K. Mittal, K. Singh, S. Misra, and G. Chaudhuri (2011)
J. Biol. Chem. 286, 469-479
   Abstract »    Full Text »    PDF »
Antizyme Restrains Centrosome Amplification by Regulating the Accumulation of Mps1 at Centrosomes.
C. Kasbek, C.-H. Yang, and H. A. Fisk (2010)
Mol. Biol. Cell 21, 3878-3889
   Abstract »    Full Text »    PDF »
Critical Factors Determining Dimerization of Human Antizyme Inhibitor.
K.-L. Su, Y.-F. Liao, H.-C. Hung, and G.-Y. Liu (2009)
J. Biol. Chem. 284, 26768-26777
   Abstract »    Full Text »    PDF »
Commitment of 1-Methyl-4-phenylpyrinidinium Ion-induced Neuronal Cell Death by Proteasome-mediated Degradation of p35 Cyclin-dependent Kinase 5 Activator.
R. Endo, T. Saito, A. Asada, H. Kawahara, T. Ohshima, and S.-i. Hisanaga (2009)
J. Biol. Chem. 284, 26029-26039
   Abstract »    Full Text »    PDF »
Antizyme is necessary for conversion of pancreatic tumor cells into glucagon-producing differentiated cells.
J.-i. Suzuki, Y. Murakami, K. Samejima, K. K. M. Ohtani, and T. Oka (2009)
Endocr. Relat. Cancer 16, 649-659
   Abstract »    Full Text »    PDF »
PKR and PKR-like Endoplasmic Reticulum Kinase Induce the Proteasome-dependent Degradation of Cyclin D1 via a Mechanism Requiring Eukaryotic Initiation Factor 2{alpha} Phosphorylation.
J. F. Raven, D. Baltzis, S. Wang, Z. Mounir, A. I. Papadakis, H. Q. Gao, and A. E. Koromilas (2008)
J. Biol. Chem. 283, 3097-3108
   Abstract »    Full Text »    PDF »
Association of OAZ1 Gene Polymorphisms With Subclinical and Clinical Vascular Events.
J. Dumont, M. Zureik, C. Bauters, M.-C. Grupposo, D. Cottel, M. Montaye, M. Hamon, P. Ducimetiere, P. Amouyel, and T. Brousseau (2007)
Arterioscler Thromb Vasc Biol 27, 2120-2126
   Abstract »    Full Text »    PDF »
Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency-mediated growth suppression.
E. Nurtjahja-Tjendraputra, D. Fu, J. M. Phang, and D. R. Richardson (2007)
Blood 109, 4045-4054
   Abstract »    Full Text »    PDF »
Ribosomal frameshifting in decoding antizyme mRNAs from yeast and protists to humans: close to 300 cases reveal remarkable diversity despite underlying conservation.
I. P. Ivanov and J. F. Atkins (2007)
Nucleic Acids Res. 35, 1842-1858
   Abstract »    Full Text »    PDF »
Molecular Basis for the Antiproliferative Effect of Agmatine in Tumor Cells of Colonic, Hepatic, and Neuronal Origin.
C. Wolf, M. Bruss, B. Hanisch, M. Gothert, I. von Kugelgen, and G. J. Molderings (2007)
Mol. Pharmacol. 71, 276-283
   Abstract »    Full Text »    PDF »
Mouse Ornithine Decarboxylase-like Gene Encodes an Antizyme Inhibitor Devoid of Ornithine and Arginine Decarboxylating Activity.
A. J. Lopez-Contreras, C. Lopez-Garcia, C. Jimenez-Cervantes, A. Cremades, and R. Penafiel (2006)
J. Biol. Chem. 281, 30896-30906
   Abstract »    Full Text »    PDF »
Regulation of cell proliferation by the antizyme inhibitor: evidence for an antizyme-independent mechanism.
S. W. Kim, U. Mangold, C. Waghorne, A. Mobascher, L. Shantz, J. Banyard, and B. R. Zetter (2006)
J. Cell Sci. 119, 2583-2591
   Abstract »    Full Text »    PDF »
Regulation of Ornithine Decarboxylase.
A. E. Pegg (2006)
J. Biol. Chem. 281, 14529-14532
   Abstract »    Full Text »    PDF »
Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis.
D. J. Feith, S. Origanti, P. L. Shoop, S. Sass-Kuhn, and L. M. Shantz (2006)
Carcinogenesis 27, 1090-1098
   Abstract »    Full Text »    PDF »
Cell Cycle Perturbations Induced by Infection with the Coronavirus Infectious Bronchitis Virus and Their Effect on Virus Replication.
B. Dove, G. Brooks, K. Bicknell, T. Wurm, and J. A. Hiscox (2006)
J. Virol. 80, 4147-4156
   Abstract »    Full Text »    PDF »
Evolutionary specialization of recoding: Frameshifting in the expression of S. cerevisiae antizyme mRNA is via an atypical antizyme shift site but is still +1.
I. P. IVANOV, R. F. GESTELAND, and J. F. ATKINS (2006)
RNA 12, 332-337
   Abstract »    Full Text »    PDF »
Characterization of a Counterpart to Mammalian Ornithine Decarboxylase Antizyme in Prokaryotes.
Y. Yamaguchi, Y. Takatsuka, S. Matsufuji, Y. Murakami, and Y. Kamio (2006)
J. Biol. Chem. 281, 3995-4001
   Abstract »    Full Text »    PDF »
Method for targeting protein destruction by using a ubiquitin-independent, proteasome-mediated degradation pathway.
S.-i. Matsuzawa, M. Cuddy, T. Fukushima, and J. C. Reed (2005)
PNAS 102, 14982-14987
   Abstract »    Full Text »    PDF »
c-myc Promoter-binding Protein 1 (MBP-1) Regulates Prostate Cancer Cell Growth by Inhibiting MAPK Pathway.
A. K. Ghosh, R. Steele, and R. B. Ray (2005)
J. Biol. Chem. 280, 14325-14330
   Abstract »    Full Text »    PDF »
Degradation of Antizyme Inhibitor, an Ornithine Decarboxylase Homologous Protein, Is Ubiquitin-dependent and Is Inhibited by Antizyme.
Z. Bercovich and C. Kahana (2004)
J. Biol. Chem. 279, 54097-54102
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882